Questionnaires and activity monitors that evaluate
functional status may play an important role in
describing the benefits of interventions in patients
with peripheral arterial disease (PAD). One such
instrument is the Walking Impairment Questionnaire
(WIQ), which has been developed and validated
to quantify the ability to walk defined distances,
speeds, and stairs and to characterize the symptoms
that limit walking ability in patients with PAD .4